Global Antiviral Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Antiviral Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Antiviral therapy is one of the most exciting branches of virology. It entails several strategies used to develop antiviral therapy, including direct-acting antivirals that target viral proteins, enzymes, or nucleic acids; passive antibodies that neutralize viruses circulating in drug; and drugs that target cellular proteins or processes essential for viral replication.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Antiviral Therapy industry chain, the market status of HIV (Generic Drugs, Branded Drugs), Hepatitis (Generic Drugs, Branded Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiviral Therapy.

Regionally, the report analyzes the Antiviral Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiviral Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Antiviral Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiviral Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Generic Drugs, Branded Drugs).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiviral Therapy market.

Regional Analysis: The report involves examining the Antiviral Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiviral Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Antiviral Therapy:
Company Analysis: Report covers individual Antiviral Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiviral Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (HIV, Hepatitis).

Technology Analysis: Report covers specific technologies relevant to Antiviral Therapy. It assesses the current state, advancements, and potential future developments in Antiviral Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiviral Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Antiviral Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Generic Drugs
    Branded Drugs

Market segment by Application
    HIV
    Hepatitis
    Herpes
    Virus Influenza
    Others

Market segment by players, this report covers
    AbbVie Inc.
    Abbott
    F. Hoffmann-La Roche Ltd
    Bristol-Myers Squibb Company
    Johnson & Johnson Services, Inc.
    Merck & Co., Inc.
    Gilead Sciences, Inc.
    GlaxoSmithKline plc
    Aurobindo Pharma
    AstraZeneca

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antiviral Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antiviral Therapy, with revenue, gross margin and global market share of Antiviral Therapy from 2019 to 2024.
Chapter 3, the Antiviral Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antiviral Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiviral Therapy.
Chapter 13, to describe Antiviral Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Antiviral Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Antiviral Therapy by Type
        1.3.1 Overview: Global Antiviral Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Antiviral Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Generic Drugs
        1.3.4 Branded Drugs
    1.4 Global Antiviral Therapy Market by Application
        1.4.1 Overview: Global Antiviral Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 HIV
        1.4.3 Hepatitis
        1.4.4 Herpes
        1.4.5 Virus Influenza
        1.4.6 Others
    1.5 Global Antiviral Therapy Market Size & Forecast
    1.6 Global Antiviral Therapy Market Size and Forecast by Region
        1.6.1 Global Antiviral Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Antiviral Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Antiviral Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Antiviral Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Antiviral Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Antiviral Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Antiviral Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 AbbVie Inc.
        2.1.1 AbbVie Inc. Details
        2.1.2 AbbVie Inc. Major Business
        2.1.3 AbbVie Inc. Antiviral Therapy Product and Solutions
        2.1.4 AbbVie Inc. Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 AbbVie Inc. Recent Developments and Future Plans
    2.2 Abbott
        2.2.1 Abbott Details
        2.2.2 Abbott Major Business
        2.2.3 Abbott Antiviral Therapy Product and Solutions
        2.2.4 Abbott Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Abbott Recent Developments and Future Plans
    2.3 F. Hoffmann-La Roche Ltd
        2.3.1 F. Hoffmann-La Roche Ltd Details
        2.3.2 F. Hoffmann-La Roche Ltd Major Business
        2.3.3 F. Hoffmann-La Roche Ltd Antiviral Therapy Product and Solutions
        2.3.4 F. Hoffmann-La Roche Ltd Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
    2.4 Bristol-Myers Squibb Company
        2.4.1 Bristol-Myers Squibb Company Details
        2.4.2 Bristol-Myers Squibb Company Major Business
        2.4.3 Bristol-Myers Squibb Company Antiviral Therapy Product and Solutions
        2.4.4 Bristol-Myers Squibb Company Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
    2.5 Johnson & Johnson Services, Inc.
        2.5.1 Johnson & Johnson Services, Inc. Details
        2.5.2 Johnson & Johnson Services, Inc. Major Business
        2.5.3 Johnson & Johnson Services, Inc. Antiviral Therapy Product and Solutions
        2.5.4 Johnson & Johnson Services, Inc. Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Johnson & Johnson Services, Inc. Recent Developments and Future Plans
    2.6 Merck & Co., Inc.
        2.6.1 Merck & Co., Inc. Details
        2.6.2 Merck & Co., Inc. Major Business
        2.6.3 Merck & Co., Inc. Antiviral Therapy Product and Solutions
        2.6.4 Merck & Co., Inc. Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Merck & Co., Inc. Recent Developments and Future Plans
    2.7 Gilead Sciences, Inc.
        2.7.1 Gilead Sciences, Inc. Details
        2.7.2 Gilead Sciences, Inc. Major Business
        2.7.3 Gilead Sciences, Inc. Antiviral Therapy Product and Solutions
        2.7.4 Gilead Sciences, Inc. Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Gilead Sciences, Inc. Recent Developments and Future Plans
    2.8 GlaxoSmithKline plc
        2.8.1 GlaxoSmithKline plc Details
        2.8.2 GlaxoSmithKline plc Major Business
        2.8.3 GlaxoSmithKline plc Antiviral Therapy Product and Solutions
        2.8.4 GlaxoSmithKline plc Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 GlaxoSmithKline plc Recent Developments and Future Plans
    2.9 Aurobindo Pharma
        2.9.1 Aurobindo Pharma Details
        2.9.2 Aurobindo Pharma Major Business
        2.9.3 Aurobindo Pharma Antiviral Therapy Product and Solutions
        2.9.4 Aurobindo Pharma Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Aurobindo Pharma Recent Developments and Future Plans
    2.10 AstraZeneca
        2.10.1 AstraZeneca Details
        2.10.2 AstraZeneca Major Business
        2.10.3 AstraZeneca Antiviral Therapy Product and Solutions
        2.10.4 AstraZeneca Antiviral Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 AstraZeneca Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Antiviral Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Antiviral Therapy by Company Revenue
        3.2.2 Top 3 Antiviral Therapy Players Market Share in 2023
        3.2.3 Top 6 Antiviral Therapy Players Market Share in 2023
    3.3 Antiviral Therapy Market: Overall Company Footprint Analysis
        3.3.1 Antiviral Therapy Market: Region Footprint
        3.3.2 Antiviral Therapy Market: Company Product Type Footprint
        3.3.3 Antiviral Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Antiviral Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Antiviral Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Antiviral Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Antiviral Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Antiviral Therapy Consumption Value by Type (2019-2030)
    6.2 North America Antiviral Therapy Consumption Value by Application (2019-2030)
    6.3 North America Antiviral Therapy Market Size by Country
        6.3.1 North America Antiviral Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Antiviral Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Antiviral Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Antiviral Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Antiviral Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Antiviral Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Antiviral Therapy Market Size by Country
        7.3.1 Europe Antiviral Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Antiviral Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Antiviral Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Antiviral Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Antiviral Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Antiviral Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Antiviral Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Antiviral Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Antiviral Therapy Market Size by Region
        8.3.1 Asia-Pacific Antiviral Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Antiviral Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Antiviral Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Antiviral Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Antiviral Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Antiviral Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Antiviral Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Antiviral Therapy Consumption Value by Type (2019-2030)
    9.2 South America Antiviral Therapy Consumption Value by Application (2019-2030)
    9.3 South America Antiviral Therapy Market Size by Country
        9.3.1 South America Antiviral Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Antiviral Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Antiviral Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Antiviral Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Antiviral Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Antiviral Therapy Market Size by Country
        10.3.1 Middle East & Africa Antiviral Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Antiviral Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Antiviral Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Antiviral Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Antiviral Therapy Market Drivers
    11.2 Antiviral Therapy Market Restraints
    11.3 Antiviral Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Antiviral Therapy Industry Chain
    12.2 Antiviral Therapy Upstream Analysis
    12.3 Antiviral Therapy Midstream Analysis
    12.4 Antiviral Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Antiviral Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Antiviral Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Antiviral Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Antiviral Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. AbbVie Inc. Company Information, Head Office, and Major Competitors
    Table 6. AbbVie Inc. Major Business
    Table 7. AbbVie Inc. Antiviral Therapy Product and Solutions
    Table 8. AbbVie Inc. Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. AbbVie Inc. Recent Developments and Future Plans
    Table 10. Abbott Company Information, Head Office, and Major Competitors
    Table 11. Abbott Major Business
    Table 12. Abbott Antiviral Therapy Product and Solutions
    Table 13. Abbott Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Abbott Recent Developments and Future Plans
    Table 15. F. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors
    Table 16. F. Hoffmann-La Roche Ltd Major Business
    Table 17. F. Hoffmann-La Roche Ltd Antiviral Therapy Product and Solutions
    Table 18. F. Hoffmann-La Roche Ltd Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
    Table 20. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
    Table 21. Bristol-Myers Squibb Company Major Business
    Table 22. Bristol-Myers Squibb Company Antiviral Therapy Product and Solutions
    Table 23. Bristol-Myers Squibb Company Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Bristol-Myers Squibb Company Recent Developments and Future Plans
    Table 25. Johnson & Johnson Services, Inc. Company Information, Head Office, and Major Competitors
    Table 26. Johnson & Johnson Services, Inc. Major Business
    Table 27. Johnson & Johnson Services, Inc. Antiviral Therapy Product and Solutions
    Table 28. Johnson & Johnson Services, Inc. Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Johnson & Johnson Services, Inc. Recent Developments and Future Plans
    Table 30. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
    Table 31. Merck & Co., Inc. Major Business
    Table 32. Merck & Co., Inc. Antiviral Therapy Product and Solutions
    Table 33. Merck & Co., Inc. Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Merck & Co., Inc. Recent Developments and Future Plans
    Table 35. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
    Table 36. Gilead Sciences, Inc. Major Business
    Table 37. Gilead Sciences, Inc. Antiviral Therapy Product and Solutions
    Table 38. Gilead Sciences, Inc. Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Gilead Sciences, Inc. Recent Developments and Future Plans
    Table 40. GlaxoSmithKline plc Company Information, Head Office, and Major Competitors
    Table 41. GlaxoSmithKline plc Major Business
    Table 42. GlaxoSmithKline plc Antiviral Therapy Product and Solutions
    Table 43. GlaxoSmithKline plc Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. GlaxoSmithKline plc Recent Developments and Future Plans
    Table 45. Aurobindo Pharma Company Information, Head Office, and Major Competitors
    Table 46. Aurobindo Pharma Major Business
    Table 47. Aurobindo Pharma Antiviral Therapy Product and Solutions
    Table 48. Aurobindo Pharma Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Aurobindo Pharma Recent Developments and Future Plans
    Table 50. AstraZeneca Company Information, Head Office, and Major Competitors
    Table 51. AstraZeneca Major Business
    Table 52. AstraZeneca Antiviral Therapy Product and Solutions
    Table 53. AstraZeneca Antiviral Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. AstraZeneca Recent Developments and Future Plans
    Table 55. Global Antiviral Therapy Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Antiviral Therapy Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Antiviral Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Antiviral Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Antiviral Therapy Players
    Table 60. Antiviral Therapy Market: Company Product Type Footprint
    Table 61. Antiviral Therapy Market: Company Product Application Footprint
    Table 62. Antiviral Therapy New Market Entrants and Barriers to Market Entry
    Table 63. Antiviral Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Antiviral Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Antiviral Therapy Consumption Value Share by Type (2019-2024)
    Table 66. Global Antiviral Therapy Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Antiviral Therapy Consumption Value by Application (2019-2024)
    Table 68. Global Antiviral Therapy Consumption Value Forecast by Application (2025-2030)
    Table 69. North America Antiviral Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Antiviral Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Antiviral Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America Antiviral Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America Antiviral Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Antiviral Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Antiviral Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Antiviral Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Antiviral Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe Antiviral Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe Antiviral Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Antiviral Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Antiviral Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Antiviral Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Antiviral Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Antiviral Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Antiviral Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Antiviral Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Antiviral Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Antiviral Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Antiviral Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America Antiviral Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America Antiviral Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Antiviral Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Antiviral Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Antiviral Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Antiviral Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Antiviral Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Antiviral Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Antiviral Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Antiviral Therapy Raw Material
    Table 100. Key Suppliers of Antiviral Therapy Raw Materials
List of Figures
    Figure 1. Antiviral Therapy Picture
    Figure 2. Global Antiviral Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Antiviral Therapy Consumption Value Market Share by Type in 2023
    Figure 4. Generic Drugs
    Figure 5. Branded Drugs
    Figure 6. Global Antiviral Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Antiviral Therapy Consumption Value Market Share by Application in 2023
    Figure 8. HIV Picture
    Figure 9. Hepatitis Picture
    Figure 10. Herpes Picture
    Figure 11. Virus Influenza Picture
    Figure 12. Others Picture
    Figure 13. Global Antiviral Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Antiviral Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Antiviral Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Antiviral Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Antiviral Therapy Consumption Value Market Share by Region in 2023
    Figure 18. North America Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Antiviral Therapy Revenue Share by Players in 2023
    Figure 24. Antiviral Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Antiviral Therapy Market Share in 2023
    Figure 26. Global Top 6 Players Antiviral Therapy Market Share in 2023
    Figure 27. Global Antiviral Therapy Consumption Value Share by Type (2019-2024)
    Figure 28. Global Antiviral Therapy Market Share Forecast by Type (2025-2030)
    Figure 29. Global Antiviral Therapy Consumption Value Share by Application (2019-2024)
    Figure 30. Global Antiviral Therapy Market Share Forecast by Application (2025-2030)
    Figure 31. North America Antiviral Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Antiviral Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Antiviral Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Antiviral Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Antiviral Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Antiviral Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Antiviral Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Antiviral Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Antiviral Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Antiviral Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Antiviral Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Antiviral Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Antiviral Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Antiviral Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Antiviral Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Antiviral Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 65. Antiviral Therapy Market Drivers
    Figure 66. Antiviral Therapy Market Restraints
    Figure 67. Antiviral Therapy Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Antiviral Therapy in 2023
    Figure 70. Manufacturing Process Analysis of Antiviral Therapy
    Figure 71. Antiviral Therapy Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Companies Mentioned

AbbVie Inc.
Abbott
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Aurobindo Pharma
AstraZeneca